114 filings
Page 4 of 6
CORRESP
xhxzturyqu743y ejmb
26 Apr 22
Correspondence with SEC
12:00am
UPLOAD
mw3rwgqeu66s
23 Mar 22
Letter from SEC
12:00am
S-3
v9kjj8 o18hvi6z6p4
18 Mar 22
Shelf registration
4:11pm
8-K
44k2i
17 Mar 22
Virios Therapeutics Announces Fourth Quarter and Full Year 2021 Financial Results and Provides Corporate Update
7:31am
8-K
yhont k6gkj
1 Mar 22
Regulation FD Disclosure
5:15pm
8-K
8p01yn b36w3xss
17 Dec 21
Other Events
7:05am
8-K
v7u afsava
12 Nov 21
Virios Therapeutics Announces Third Quarter 2021 Financial Results and Provides Corporate Update
7:06am
8-K
84rc5
12 Oct 21
Regulation FD Disclosure
12:32pm
8-K
8jwcbqe6h0q woj
12 Aug 21
Virios Therapeutics Announces Second Quarter 2021 Financial Results and Provides Corporate Update
10:45am
8-K
nh8fc5491kbr
24 Jun 21
Submission of Matters to a Vote of Security Holders
11:00am
DEFA14A
f02x62we0p1rfl 4c
3 Jun 21
Additional proxy soliciting materials
7:05am
10-Q
ndu6 1kky9mlyq
14 May 21
Quarterly report
8:14am
8-K
vxf8 4m4n
14 May 21
Regulation FD Disclosure
7:05am
8-K
qqu4oe90io6eo k9zyo
13 May 21
Departure of Directors or Certain Officers
7:46am
8-K
f4ydd3b2g cjd9g
13 May 21
Virios Therapeutics Announces First Quarter 2021 Financial Results and Provides Corporate Update
7:37am
DEFA14A
o8kp72
28 Apr 21
Additional proxy soliciting materials
4:10pm
DEF 14A
r4ly8iekmmzgbdj4s
28 Apr 21
Definitive proxy
4:05pm